Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302) - Rathkopf, D E; Smith, M R; de Bono, J S (Eur Urol, 2014)
et al.